[Effect of cosaldon A + E in presbycusis. Tone and speech audiometric studies].
D000368:Aged; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D006319:Hearing Loss, Sensorineural / Q000188:drug therapy*; D006320:Hearing Tests; D006801:Humans; D008297:Male; D009539:Nicotinic Acids / Q000627:therapeutic use*; D011304:Presbycusis / Q000188:drug therapy*; D013805:Theobromine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014801:Vitamin A / Q000627:therapeutic use*; D014810:Vitamin E / Q000627:therapeutic use*
D004338:Drug Combinations; D009539:Nicotinic Acids; D014801:Vitamin A; D014810:Vitamin E; C025790:vitamin A, pentifyllin, nicotinic acid, and vitamin E combination; D013805:Theobromine
Wirksamkeit von Cosaldon A + E bei Presbyakusis. Ton- und sprachaudiometrische Untersuchungen.